Compare Flex Ltd (FLEX) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flex Ltd vs ImmunityBio Inc. Common Stock — how do they compare? Flex Ltd trades at $116.02 (market cap $44.09B), while ImmunityBio Inc. Common Stock trades at $10.02 (market cap $10.33B). The key difference: Flex Ltd is far larger — about 4.3× ImmunityBio Inc. Common Stock's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Flex Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Flex Ltd for 3 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| FLEX | IBRX | |
|---|---|---|
Market Cap | $44.09B | $10.33B |
Volume | 3,022,166 | 11,745,198 |
Sector | Technology | Health |
52-Week High | $162.07 | $11.55 |
52-Week Low | $54.51 | $1.98 |
Typical Hold Time | 3 Days | 0 Days |
Enterprise Value | $47.18B | $10.79B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Flex Ltd
Flex provides design, engineering, manufacturing, supply chain, and logistics services for technology products. It serves industries including cloud, data centers, communications, automotive, healthcare, and industrials.
Read more on FLEX →About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →
